BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 35962368)

  • 1. The CHAMP-study: the CHemopreventive effect of lithium in familial AdenoMatous Polyposis; study protocol of a phase II trial.
    Linssen JDG; van Neerven SM; Aelvoet AS; Elbers CC; Vermeulen L; Dekker E
    BMC Gastroenterol; 2022 Aug; 22(1):383. PubMed ID: 35962368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resorting the function of the colorectal cancer gatekeeper adenomatous polyposis coli.
    Kariv R; Caspi M; Fliss-Isakov N; Shorer Y; Shor Y; Rosner G; Brazowski E; Beer G; Cohen S; Rosin-Arbesfeld R
    Int J Cancer; 2020 Feb; 146(4):1064-1074. PubMed ID: 31283021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of eflornithine (CPP-1X)/sulindac combination therapy versus each as monotherapy in patients with familial adenomatous polyposis (FAP): design and rationale of a randomized, double-blind, Phase III trial.
    Burke CA; Dekker E; Samadder NJ; Stoffel E; Cohen A
    BMC Gastroenterol; 2016 Aug; 16(1):87. PubMed ID: 27480131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted next-generation sequencing approach for molecular genetic diagnosis of hereditary colorectal cancer: Identification of a novel single nucleotide germline insertion in adenomatous polyposis coli gene causes familial adenomatous polyposis.
    Wang D; Liang S; Zhang X; Dey SK; Li Y; Xu C; Yu Y; Li M; Zhao G; Zhang Z
    Mol Genet Genomic Med; 2019 Jan; 7(1):e00505. PubMed ID: 30523670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Germline mutations of the adenomatous polyposis coli (APC) gene in Algerian familial adenomatous polyposis cohort: first report.
    Khider F; Cherbal F; Boumehdi AL; Layaida K; Mahfouf H; Zebboudj F; Maaoui M
    Mol Biol Rep; 2022 May; 49(5):3823-3837. PubMed ID: 35142982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of APC and MUTYH mutations to familial adenomatous polyposis susceptibility in Hungary.
    Papp J; Kovacs ME; Matrai Z; Orosz E; Kásler M; Børresen-Dale AL; Olah E
    Fam Cancer; 2016 Jan; 15(1):85-97. PubMed ID: 26446593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel pathogenic large germline deletion in adenomatous polyposis coli gene in a Chinese family with familial adenomatous polyposis.
    Zhang Z; Liang S; Huang H; Wang D; Zhang X; Wu J; Chen H; Wang Y; Rong T; Zhou Y; Banerjee S
    Oncotarget; 2016 Aug; 7(31):50392-50400. PubMed ID: 27391059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variables affecting penetrance of gastric and duodenal phenotype in familial adenomatous polyposis patients.
    Sample DC; Samadder NJ; Pappas LM; Boucher KM; Samowitz WS; Berry T; Westover M; Nathan D; Kanth P; Byrne KR; Burt RW; Neklason DW
    BMC Gastroenterol; 2018 Jul; 18(1):115. PubMed ID: 30012100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel large germ line deletion in adenomatous polyposis coli (APC) gene associated with familial adenomatous polyposis.
    Pouya F; Mojtabanezhad Shariatpanahi A; Ghaffarzadegan K; Tabatabaee Yazdi SA; Golmohammadzadeh H; Soltani G; Aminian Toosi K; Kerachian MA
    Mol Genet Genomic Med; 2018 Nov; 6(6):1031-1040. PubMed ID: 30259713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synonymous mutation adenomatous polyposis coliΔ486s affects exon splicing and may predispose patients to adenomatous polyposis coli/mutY DNA glycosylase mutation‑negative familial adenomatous polyposis.
    Liu WQ; Dong J; Peng YX; Li WL; Yang J
    Mol Med Rep; 2018 Dec; 18(6):4931-4939. PubMed ID: 30272267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. APC or MUTYH mutations account for the majority of clinically well-characterized families with FAP and AFAP phenotype and patients with more than 30 adenomas.
    Filipe B; Baltazar C; Albuquerque C; Fragoso S; Lage P; Vitoriano I; Mão de Ferro S; Claro I; Rodrigues P; Fidalgo P; Chaves P; Cravo M; Nobre Leitão C
    Clin Genet; 2009 Sep; 76(3):242-55. PubMed ID: 19793053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Pathways of Carcinogenesis in Familial Adenomatous Polyposis.
    Ditonno I; Novielli D; Celiberto F; Rizzi S; Rendina M; Ierardi E; Di Leo A; Losurdo G
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A neoepitope derived from a novel human germline APC gene mutation in familial adenomatous polyposis shows selective immunogenicity.
    Majumder S; Shah R; Elias J; Mistry Y; Coral K; Shah P; Maurya AK; Mittal B; D'Silva JK; Murugan S; Mahadevan L; Sathian R; Ramprasad VL; Chakraborty P; Gupta R; Chaudhuri A; Khanna-Gupta A
    PLoS One; 2018; 13(9):e0203845. PubMed ID: 30256815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutational screening through comprehensive bioinformatics analysis to detect novel germline mutations in the APC gene in patients with familial adenomatous polyposis (FAP).
    Ghadamyari F; Heidari MM; Zeinali S; Khatami M; Merat S; Bagherian H; Rejali L; Ghasemi F
    J Clin Lab Anal; 2021 May; 35(5):e23768. PubMed ID: 33769591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T cell migration and effector function differences in familial adenomatous polyposis patients with
    Cuche C; Mastrogiovanni M; Juzans M; Laude H; Ungeheuer MN; Krentzel D; Gariboldi MI; Scott-Algara D; Madec M; Goyard S; Floch C; Chauveau-Le Friec G; Lafaye P; Renaudat C; Le Bidan M; Micallef C; Schmutz S; Mella S; Novault S; Hasan M; Duffy D; Di Bartolo V; Alcover A
    Front Immunol; 2023; 14():1163466. PubMed ID: 37533857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of K-ras, APC, and beta-catenin in aberrant crypt foci in sporadic adenoma, cancer, and familial adenomatous polyposis.
    Takayama T; Ohi M; Hayashi T; Miyanishi K; Nobuoka A; Nakajima T; Satoh T; Takimoto R; Kato J; Sakamaki S; Niitsu Y
    Gastroenterology; 2001 Sep; 121(3):599-611. PubMed ID: 11522744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of two novel adenomatous polyposis coli (APC) gene mutations in patients with familial adenomatous polyposis (FAP).
    Bapat B; Berk T; Mitri A; Cohen Z; Gallinger S; Stern H
    Hum Mutat; 1994; 4(4):253-6. PubMed ID: 7866403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. APC mosaicism in a young woman with desmoid type fibromatosis and familial adenomatous polyposis.
    Stormorken AT; Berg T; Norum OJ; Hølmebakk T; Aaberg K; Steigen SE; Grindedal EM
    Fam Cancer; 2018 Oct; 17(4):539-543. PubMed ID: 29368261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two subtypes of colorectal tumor with distinct molecular features in familial adenomatous polyposis.
    Takane K; Matsusaka K; Ota S; Fukuyo M; Yue Y; Nishimura M; Sakai E; Matsushita K; Miyauchi H; Aburatani H; Nakatani Y; Takayama T; Matsubara H; Akagi K; Kaneda A
    Oncotarget; 2016 Dec; 7(51):84003-84016. PubMed ID: 27563825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemoprevention of colorectal cancer: systematic review and economic evaluation.
    Cooper K; Squires H; Carroll C; Papaioannou D; Booth A; Logan RF; Maguire C; Hind D; Tappenden P
    Health Technol Assess; 2010 Jun; 14(32):1-206. PubMed ID: 20594533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.